Rebate agreements for the active ingredient Sorafenib (ATC L01EX02)

Rebate agreements for the active ingredient Sorafenib (ATC L01EX02): Conclusion under an "Open House model" with all interested pharmaceutical companies without selection. The contracts are non-exclusive and subject to uniform conditions without individual negotiations. The maximum contract duration is 24 months, with the earliest contract start on 01.10.2026. All contracts end no later than 24 months after the earliest contract start. Accession is possible monthly on the first of each month. There is a right of termination with 6 weeks' notice to the end of the month. AOK Rheinland-Pfalz/Saarland reserves the right to replace the Open House contracts with exclusive contracts during the term, which will automatically terminate the Open House contracts. Contract information and documents are accessible after registration and activation in the project room on www.dtvp.de. Submission of documents is preferably electronic with a qualified electronic signature via email to am_vertraege@rps.aok.de or alternatively in 2-fold written form (scan via email first) to AOK Rheinland-Pfalz/Saarland, Strategisches Vertragsmanagement Arzneimittel, Virchowstraße 30, 67304 Eisenberg. Potential contractors are exclusively pharmaceutical companies; the documents must be treated as strictly confidential. For a contract start on 01.10.2026, documents must be submitted by 31.08.2026. For later contract starts, documents must be received by the end of the month preceding the month before the desired start. The first award will be made no earlier than 10 calendar days after publication of the EU notice. This publication serves transparency and does not constitute a public contract within the meaning of Procurement Coordination Directive 2014/24/EU.

Tender documents

Additional details